Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological correlates of protection against measles in once-vaccinated children
NL-OMON32077Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of measles, mumps, and rubella vaccine in measles, sponsored by National Institute for Public Health and the Environment. Primary endpoint: Serological correlates of protection against clinical measles and measles virus infection. Started Jul 2013; status: active, not recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
measles
Beyond the preview
Go deeper on NL-OMON32077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32077.